文献速递瓣膜病与结构性心脏病

低至中外科风险重度主动脉瓣狭窄患者TAVI与SAVR五年结局更新:系统评价与Meta分析

Updated 5-year outcomes of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low- to intermediate-surgical risk.
PubMed 文献 · Heart · 2026-02-11

该研究采用贝叶斯分层设计的系统评价与Meta分析,纳入6项至少随访5年的随机对照试验,共7249例低至中外科风险的重度主动脉瓣狭窄患者。结果显示,TAVI组5年全因死亡率29.7%,SAVR组27.6%,全因死亡RR 1.12(95%CrI 1.02-1.22),SAVR优于TAVI的后验概率99.3%;卒中RR 1.13(95%CrI 0.93-1.39),SAVR更优的后验概率88.0%。

要点

  • 低至中外科风险患者TAVI术后5年全因死亡风险较SAVR升高,RR 1.12(95%CrI 1.02-1.22)。
  • TAVI组5年卒中风险可能升高,RR 1.13(95%CrI 0.93-1.39),后验概率88.0%。
  • 外科风险类别未见交互效应(p=0.470)。

核心结论

  • 在低至中外科风险重度主动脉瓣狭窄患者中,TAVI较SAVR在5年随访时全因死亡率有临床相关升高,且卒中风险升高的概率较高。

研究设计与样本

  • 系统评价与Meta分析,采用贝叶斯分层设计,纳入比较TAVI与SAVR且至少随访5年的随机对照试验。
  • 共纳入6项随机对照试验,7249例低至中外科风险患者(TAVI n=3704,SAVR n=3545)。

主要发现

  • 5年全因死亡率:TAVI 29.7%(28.2-31.2%),SAVR 27.6%(26.1-29.1%)。
  • 全因死亡RR中位数1.12(95%CrI 1.02-1.22,异质性τ2=0),SAVR优于TAVI的后验概率99.3%。
  • 卒中RR中位数1.13(95%CrI 0.93-1.39,异质性τ2=0.04),SAVR优于TAVI的后验概率88.0%。
  • 频率学派随机效应模型RR 1.13(95%CI 1.05-1.22,p=0.001),固定效应模型RR 1.12(95%CI 1.03-1.23,p=0.011)。
  • 外科风险类别交互效应无统计学意义(p=0.470)。

临床怎么用

  • 在低至中外科风险重度主动脉瓣狭窄患者选择TAVI或SAVR时,应将5年全因死亡和卒中风险纳入共同决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The comparative long-term safety and efficacy of transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) remains under continued investigation, particularly in patients at low- to intermediate-surgical risk. This study aims to synthesise and update contemporary long-term TAVI versus SAVR data. METHODS: This study comprised a systematic review and meta-analysis and employed a Bayesian hierarchical design. Randomised controlled trials (RCTs) comparing TAVI to SAVR in low-risk to intermediate-risk patients with at least 5-year follow-up were included. The primary outcome was 5-year all-cause mortality; secondary outcomes were the 5-year incidence of stroke and the 5-year incidence of the composite of mortality and stroke. REVIEW METHODS: Time-to-event data were reconstructed. Relative risks (RRs) with 95% credible intervals (CrIs) were estimated from reported 5-year event rates using minimally informative priors. Sensitivity analyses were performed using various meta-analytical models, and using conventional frequentist random-effects and fixed-effects models for sensitivity purposes. RESULTS: A total of six RCTs, enrolling 7249 low- to intermediate-risk patients reported 5-year outcomes (TAVI n=3704, SAVR n=3545). The 5-year all-cause mortality rate was 29.7% (28.2-31.2%, TAVI) and 27.6% (26.1-29.1%, SAVR). The median RR for all-cause mortality was 1.12 (95% CrI 1.02-1.22, heterogeneity τ2=0), with a 99.3% posterior probability that SAVR is superior to TAVI for this endpoint. For stroke, the median RR was 1.13 (95% CrI 0.93-1.39, heterogeneity τ2=0.04), resulting in an 88.0% posterior probability that SAVR outperformed TAVI for this outcome. These results were consistent across conventional frequentist random-effects and fixed-effects models employing p values (RR 1.13, 95% CI 1.05 to 1.22, p=0.001, and RR 1.12, 95% CI 1.03 to 1.23, p=0.011, respectively). There was no evidence for an interaction effect of surgical risk category (p=0.470). CONCLUSION: In this meta-analysis of RCTs, TAVI resulted in a clinically relevant increase in all-cause mortality, and a high probability of an increased risk of stroke, at 5 years of follow-up in low-risk to intermediate-risk patients, when compared to SAVR.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Marin-Cuartas M, Kawczynski MJ, de Waha S, et al. Updated 5-year outcomes of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low- to intermediate-surgical risk. Heart. 2026. PMID: 41672766. doi:10.1136/heartjnl-2025-327092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。